Product Information

BUPRENORPHINE 15 MCG/HR PATCH is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $52.6954 per EA under NDC 42858058640. Its NADAC has been published 370 times since Sep 13, 2017.

FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE 15 MCG/HR PATCH

Buprenorphine
$52.6954per EA
DEA Schedule CIII

Strength

15 ug/h

NDC

42858058640

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Effective Date

8/19/2026

Active Ingredients

BUPRENORPHINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021306

FDA Approved

6/30/2010

TE Code

AB

On Market Since

7/3/2017

Pharmacological Classes

Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE 15 MCG/HR PATCH has been published 370 times since Sep 13, 2017, and over the history we have for it it has declined 47.0%. The table below summarizes its recorded NADAC range and movement.

Current price$52.6954 per EA
All-time high$111.2537 (Jun 10, 2020)
All-time low$33.1572 (Jul 17, 2024)
52-week high$52.6954
52-week low$44.1510
Median price$72.3204
Average price$76.0003
Largest weekly change+62.3% (Aug 21, 2024)
Weeks tracked370
Tracking sinceSep 13, 2017

Price History

1W

+5.1%

1M

+5.1%

3M

+17.5%

6M

+5.7%

1Y

+3.8%

3Y

-27.3%

5Y

-51.1%

All

-47.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE 15 MCG/HR PATCH?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 15 MCG/HR PATCH, manufactured by Rhodes Pharmaceuticals L.P., is $52.6954 per EA (NDC 42858058640), effective Aug 19, 2026.

How has the price of BUPRENORPHINE 15 MCG/HR PATCH changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE 15 MCG/HR PATCH has declined 47.0%. It has been tracked across 370 weekly CMS publications since Sep 13, 2017.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 15 MCG/HR PATCH?

Since Sep 13, 2017, the NADAC for BUPRENORPHINE 15 MCG/HR PATCH has ranged from a low of $33.1572 (Jul 17, 2024) to a high of $111.2537 (Jun 10, 2020), with a median of $72.3204 per EA.

Are there cheaper alternatives to BUPRENORPHINE 15 MCG/HR PATCH?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 15 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE 15 MCG/HR PATCH?

BUPRENORPHINE 15 MCG/HR PATCH (NDC 42858058640) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.